Glossary Term Name
This is a placeholder for glossary term definitions.

Fact Sheets: Research Funding Facts
Since its founding in 1970 by parents of children with type 1 diabetes, JDRF has awarded more than $1.3 billion to diabetes research, including more than $156 million in FY2008. Of this total more than $88 million represented new scientific projects. More than 85 percent of JDRF's expenditures directly support research and research-related education. In FY2008, the Foundation funded more than 1,000 centers, grants, and fellowships in 22 countries, including nearly 40 human clinical trials.
Areas of Scientific Investigation
| * Artificial Pancreas * Beta Cell Development * Beta Cell Function * Beta Cell Regeneration * Clinical Trials * Environmental Triggers * Gene Therapy * Genetics * Hypoglycemia |
* Immunology * Islet Transplantation * Nephropathy * Neuropathy * Retinopathy * Stem Cells * Technological Interventions * Tolerance * Wound Healing |
JDRF's Research Goals
JDRF has established a set of cure therapeutic goals to guide its research funding efforts. These research goal areas hold the greatest potential to lead to breakthrough cures and treatments for type 1 diabetes and its complications:
FY 2008 JDRF Research Funding
Autoimmunity: $48.5 million
Complications: $28.9 million
Metabolic Control: $15.2 million
Regeneration: $21 million
Replacement: $42.8 million
For more information, visit the JDRF Web site at http://www.jdrf.org/, or call 800-533-CURE.
NOVEMBER 2008